Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MEG3
   Synonyms MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1
   Region GRCh38_14:100779410-100861031    Sequence
   Ensembl ENSG00000214548
   RefSeq NR_002766
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name oral squamous cell carcinoma
   ICD-0-3 C06.9  M8070/3
   Methods qPCR, Western blot etc.
   Sample OSCC tissues, cell lines(SCC-15, CAL-27)
   Expression Pattern down-regulated
   Function Description

Importantly, MEG3 played a role as a tumor suppressor by inhibiting the WNT/B-catenin signaling pathway. In addition, the expression of the MEG3 was signifcantly affected by the degree of DNA methylation. It was concluded that the lncRNA MEG3 can inhibit the growth and metastasis of OSCC by negatively regulating the WNT/B-catenin signaling pathway.

   Pubmed ID 28953964
   Year 2017
   Title Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/B-catenin signaling pathway
   External Links
   Links for  MEG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  oral squamous cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.